EGFR and cancer: Together, these findings demonstrate a persistent oligoclonal nature of the model and suggest that the distinct gene expression profiles observed in the EGFR+ cancer cells are potentially influenced by their ligand usage and localization in the tumor, ultimately shaping considerable heterogeneity in signaling pathway activation patterns.